Toa plans to develop software for American market:
This article was originally published in Clinica
Executive Summary
Japanese company Toa Medical Electronics has set up a software development company in Buffalo Grove, Illinois. Sysmex InfoSystems America will cater to US customers' requirements for software products associated with the use of Toa's instruments. Toa believes it is becoming increasingly difficult to meet customer needs using software systems developed exclusively in Japan. The new subsidiary is expected to general annual revenues of Yen 400 million by 2001 and is expected to begin operations in May (Toa and Iris end litigation, see p 18).
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.